The photoperiod transducer melatonin and the immune-hematopoietic system

Journal of Photochemistry and Photobiology B: Biology

Volumn 43, Issue 3, 1998, Pages 186-192

  Maestroni, Georges J M ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Immunopharmacology; Melatonin; Melatonin receptors; Secondary immunodeficiency; T helper; Viral diseases

Indexed keywords

CELL NUCLEUS RECEPTOR; COLONY STIMULATING FACTOR; CYTOKINE; DYNORPHIN B; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KAPPA OPIATE RECEPTOR; MELATONIN; MELATONIN RECEPTOR; MEMBRANE RECEPTOR; OPIATE;

BACTERIAL INFECTION; BONE MARROW CELL; CANCER PATIENT; CONFERENCE PAPER; CYTOKINE RELEASE; HELPER CELL; HEMATOPOIESIS; HEMATOPOIETIC SYSTEM; IMMUNE SYSTEM; IMMUNOPHARMACOLOGY; IMMUNOREGULATION; MONOCYTE; PHOTOPERIODICITY; PINEAL BODY; PRIORITY JOURNAL; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; HEMATOPOIESIS; HUMANS; MELATONIN; MICE; PHOTOPERIOD; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032104323     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00107-9     Document Type: Conference Paper

References (69)

1. [1] H.-S. Yu, R.J. Reiter (Eds.), Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications, CRC Press, Boca Raton, FL, 1993.
2. [2] T. Deguchi, J. Axelrod, Control of circadian change of serotonin-N-acetyltransferase in the pineal organ by β-adrenergic receptor, Proc. Natl. Acad. Sci. USA 70 (1973) 2411-2414.
3. [3] H.-S. Yu, A.T.C. Tsin, R.J. Reiter, Melatonin: history, biosynthesis, and assay methodology, in: H.-S. Yu, R.J. Reiter (Eds.), Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications, CRC Press, Boca Raton, FL, 1993, pp. 1-17.
4. [4] S.F. Pang, P.P.N. Lee, Y.S. Chan, R.J. Reiter, Melatonin secretion and its rhythms in biological fluids, in: H.-S. Yu, R.J. Reiter (Eds.), Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications, CRC Press, Boca Raton, FL, 1993, pp. 129-155.
5. [5] G. Csaba, M. Bodocky, J. Fischer, T. Acs, The effect of pinealectomy and thymectomy on the immune capacity of the rat, Experientia 22 (1965) 168-175.
6. [6] M. Bindoni, A. Cambria, Effects of pinealectomy on the in vivo and in vitro biosynthesis of nucleic acids on the mitotic rate in some organs of the rat, Arch. Sci. Biol. 52 (1968) 271-283.
7. [7] W. Rella, V. Lapin, Immunocompetence of pinealectomized and simultaneously pinealectomized and thymectomized rats, Oncology 33 (1978) 3-6.
8. [8] B.D. Jankovic, S. Isakovic, S. Petrovic, Effect of pinealectomy on immune reactions in the rat, Immunology 8 (1970) 1-6.
9. [9] M.K. Vaughan, R.J. Reiter, Transient hypertrophy of the ventral prostate and coagulating glands and accelerated thymic involution following pinealectomy in the mouse, Texas Rep. Biol. Med. 29 (1971) 579-586.
10. [10] V. Lapin, I. Ebels, The role of the pineal gland in neuroendocrine control mechanism of neoplastic growth, J. Neural. Transm. 50 (1981) 275-282.
11. [11] P. Barath, G. Csaba, Histological changes in the lung, thymus and adrenal one and half year after pinealectomy, Acta Biol. Acad. Sci. Hung. 25 (1974) 123-125.
12. [12] G. Csaba, P. Barath, Morphological changes of thymus and the thyroid gland after postnatal extirpation of pineal body, Endocrinol. Exp. 9 (1975) 59-67.
13. [13] G.J.M. Maestroni, W. Pierpaoli, Pharmacological control of the hormonally modulated immune response, in: R. Ader ( Ed. ), Psychoneuroimmunology, Academic Press, New York, 1981, pp. 405-425.
14. [14] G.J.M. Maestroni, A. Conti, W. Pierpaoli, Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonize the imunosuppressive effect of corticosterone, J. Neuroimmunol. 13 (1986) 19-30.
15. [15] A. Conti, N. Haran-Ghera, G.J.M. Maestroni, Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis, Med. Oncol. Tumor Pharmacoth. 9 (1992) 87-92.
16. [16] J. Becker, G. Veit, R. Handgretinger, G. Attanasio, G. Bruchett, I. Trenner, D. Niethammer, D. Gupta, Circadian variations in the immunomodulatory role of the pineal gland, Neuroendocrinol. Lett. 10 (1988) 65-80.
17. [17] T.H. Champney, D.N. McMurray, Spleen morphology and lymphoproliferative activity in short photoperiod exposed hamsters, in: F. Fraschini, R.J. Reiter (Eds.), Role of Melatonin and Pineal Peptides in Neuroimmunomodulation, Plenum, London, 1991, pp. 219-225.
18. [18] V. Del Gobbo, V. Libri, N. Villani, R. Caliò, G. Nstico, Pinealectomy inhibits interleukin-2 production and natural killer activity in mice, Int. J. Immunopharmacol. 11 (1989) 567-577.
19. [19] M.S. Palermo, M. Vermeulen, M. Giordano, Modulation of antibody-dependent cellular cytotoxicity by pineal gland, in: G.J.M. Maestroni, A. Conti, A.J. Reiter (Eds.), Advances in Pineal Research, vol. 7, John Libbey, London, 1994, pp. 143-147.
20. [20] C. Haldar, D. Haussler, D. Gupta, Response of CFU-GM (colony forming units for granulocytes and macrophages) from intact and pinealectomized rat bone marrow to macrophage colony stimulating factor (rGM-CSF) and human recombinant erythropoietin (rEPO), Prog. Brain Res. 91 (1992) 323-325.
21. [21] D.E. Blask, Melatonin in oncology, in: H.-S. Yu, R.J. Reiter (Eds.), Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications, CRC Press, Boca Raton, FL, 1993, pp. 447-477.
22. [22] G.J.M. Maestroni, A. Conti, W. Pierpaoli, Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism, Clin. Exp. Immunol. 68 (1987) 384-391.
23. [23] G.J.M. Maestroni, A. Conti, W. Pierpaoli, Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism, Immunology 63 (1988) 465-469.
24. [24] G.J.M. Maestroni, A. Conti, Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin, Int. J. Immunopharmacol. 11 (1989) 333-340.
25. [25] G.J.M. Maestroni, A. Conti, The pineal neurohormone melatonin stimulates activated CD4 +, Thy-1 + cells to release opioid agonist(s) with immunoenhancing and anti-stress properties, J. Neuroimmunol. 28 (1990) 167-176.
26. [26] G.J.M. Maestroni, A. Conti, Melatonin in relation to the immune system, in: H.-S. Yu, R.J. Reiter (Eds.), Melatonin. Biosynthesis, Physiological Effects and Clinical Applications, CRC Press, Boca Raton, FL, 1993, pp. 290-306.
27. [27] G.J.M. Maestroni, The immunoneuroendocrine role of melatonin, J. Pineal Res. 14 (1993) 1-10.
28. [28] G.J.M. Maestroni, A. Conti, R.J. Reiter (Eds.), Advances in Pineal Research, vol. 7, John Libbey, London, 1994.
29. [29] M. Giordano, M.S. Palermo, Melatonin-induced enhancement of antibody dependent cellular cytotoxicity, J. Pineal Res. 10 (1991) 117-121.
30. [30] M.C. Caroleo, D. Frasca, G. Nistico, G. Doria, Melatonin as immunomodulator in immunodeficient mice, Immunopharmacology 23 (1992) 81-89.
31. [31] P. Lissoni, S. Barni, A. Ardizzoia, F. Brivio, G. Tancini, A. Conti, G.J.M. Maestroni, Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients, J. Biol. Reg. Homeos. Agents 6 (1992) 132-136.
32. [32] C. Pioli, M.C. Caroleo, G. Nistico, G. Doria, Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation, Int. J. Immunopharmacol. 15 (1993) 463-469.
33. [33] M.K. Morrey, J.A. McLachlan, C.D. Serkin, O. Bakouche, Activation of human monocytes by the pineal neurohormone melatonin, J. Immunol. 153 (1994) 2671-2680.
34. [34] D. Ben-Nathan, G.J.M. Maestroni, A. Conti, Protective effect of melatonin in mice infected with encephalitis viruses, Arch. Virol. 140s (1995) 223-230.
35. [35] D. Ben-Nathan, G.J.M. Maestroni, A. Conti, Protective effect of melatonin in viral and bacterial infections, in: G.J.M. Maestroni, A. Conti, R.J. Reiter (Eds.), Frontiers in Hormone Research, vol. 23, Karger, Basel, 1997, pp. 71-82.
36. [36] E. Bonilla, N. Valerofuenmajor, H. Pons, L. Chacin-Bonilla, Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus, Cell. Mol. Life Sci. 53 (1997) 430-434.
37. [37] G.J.M. Maestroni, Melatonin as therapeutic agent in experimental endotoxic shock, J. Pineal Res. 20 (1996) 84-89.
38. [38] M. Wichmann, R. Zellweger, A. DeMaso, A. Ayala, I. Chaudry, Melatonin administration attenuates depressed immune functions trauma-hemorrhage, J. Surg. Res. 63 (1996) 256-262.
39. [39] A. Angeli, G. Gatti, M.L. Sartori, D. Del Ponte, R. Cerignola, Effect of exogenous melatonin on human natural killer (NK) cell activity. An approach to the immunomodulatory role of the pineal gland, in D. Gupta, A. Attanasio, R.J. Reiter (Eds.), The Pineal Gland and Cancer, Müller and Bass, Tübingen, 1988, pp. 145-157.
40. [40] A. Lewinsky, P. Zelazowsky, E. Sewerynek, G. Zerek-Melen, M. Szudlinsky, Melatonin-induced immunosuppression of humal lymphocyte natural killer activity in vitro, J. Pineal Res. 7 (1989) 153-164.
41. [41] G.J.M. Maestroni, A. Conti, Anti-stress role of the melatonin-immuno-opioid network. Evidence for a physiological mechanism involving T cell-derived, immunoreactive β-endorphin and metenkephalin binding to thymic opioid receptors, Int. J. Neurosci. 61 (1991) 289-298.
42. [42] G.J.M. Maestroni, V. Covacci, A. Conti, Hematopoietic rescue via T-cell-dependent, endogenous GM-CSF by the pineal neurohormone melatonin in tumor bearing mice, Cancer Res. 54 (1994) 2429-2432.
43. [43] G.J.M. Maestroni, A. Conti, P. Lissoni, Colony-stimulating activity and hematopoietic rescue from cancer chemothereapy compounds are induced by melatonin via endogenous interleukin 4, Cancer Res. 54 (1994) 4740-4743.
44. [44] I. Hansson, R. Holmdahl, R. Mattsson, The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice, J. Neuroimmunol. 39 (1992) 23.
45. [45] L.L. Colombo, G.-J. Chen, M.C. Lopez, R.R. Watson, Melatonin induced increase in gamma-interferon production by murine splenocytes, Immunol. Lett. 33 (1992) 123-126.
46. [46] L.C. Hofbauer, A.E. Heufelder, Endocrinology meets immunology: T lymphocytes as novel targets for melatonin, Eur. J. Endocrinol. 134 (1996) 424-425.
47. [47] S. Garcia-Maurino, M. Gonzales-Haba, J.R. Calvo, M. Rafii-El-Idrissi, V. Sanchez-Margalet, R. Goberna, J.-M. Guerrero, Melatonin enhances IL-2, IL-6, and IFN-g production by human circulating CD4+ cells. A possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes, J. Immunol. 159 (1997) 574-581.
48. [48] G. Maestroni, E. Hertens, P. Galli, A. Conti, E. Pedrinis, Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin, J. Pineal Res. 21 (1996) 131-139.
49. [49] E. Ways, E. Kutoh, D. Gupta, Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat, Eur. J. Endocrinol. 133 (1995) 754-760.
50. [50] G.J.M. Maestroni, A. Conti, Melatonin and the immune-hematopoietic system therapeutic and adverse pharmacological correlates, NeuroImmunoModulation (1996) 325-332.
51. [51] M.R.I. Young, M.E. Young, K. Kim, Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2, Cancer Res. 48 (1988) 6826-6831.
52. [52] G.J.M. Maestroni, Kappa-opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin-induced opioid cytokines, Proc. 3rd Int. Congress Int. Soc. Neuroimmunomodulation, Bethesda, USA, New York Acad. Sci., 1996, in press.
53. [53] S.M. Reppert, D.R. Weaver, Melatonin madness, Cell 83 (1995) 1059-1062.
54. [54] A.M. Poon, Z.M. Liu, C.S. Pang, G.M. Brown, S.F. Pang, Evidence for a direct action of melatonin on the immune system, Biol. Signals 3 (1994) 107-117.
55. [55] G.J.M. Maestroni, T helper 2 lymphocytes as a peripheral target of melatonin, J. Pineal Res. 18 (1995) 84-89.
56. [56] R. Konakchieva, S. Kyurkchiev, I. Kehayov, P. Taushanova, L. Kanchev, Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells, J. Neuroimmunol. 63 (1995) 125-132.
57. [57] C. Carlberg, I. Wiesenberg, The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship, J. Pineal Res. 18 (1995) 171-178.
58. [58] A. Conti, G.J.M. Maestroni, The clinical neuroimmunotherapeutic role of melatonin in oncology, J. Pineal Res. 19 (1995) 103-110.
59. [59] B. Neri, C. Fiorelli, F. Moroni, G. Nicita, M.C. Paoletti, R. Ponchietti, A. Raugei, G. Santoni, A. Trippitelli, G. Grechi, Modulation of human lymphobalstoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study, Cancer 73 (1994) 3015-3019.
60. [60] P. Lissoni, F. Brivio, O. Brivio, L. Fumagalli, F. Gramazio, M. Rossi, G. Emanuelli, G. Alderi, F. Lavorato, Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients, J. Biol. Regul. Homeost. Agents 9 (1995) 31-33.
61. [61] B. Withyachumnarnkul, K.O. Nonaka, C. Santana, A.M. Attia, R.J. Reiter, Interferon-gamma modulates melatonin production in rat pineal gland in organ culture, J. Interferon Res. 10 (1990) 403-411.
62. [62] K. Zylinska, J. Komorowski, T. Robak, S. Mucha, Effect of granulocytemacrophage colony stimulating factor and granulocyte colony stimulating factor on melatonin secretion in rats in vivo and in vitro studies, J. Neuroimmunol. 56 (1995) 187-190.
63. [63] H. Stepien, R. Valcavi, M. Zini, G.J.M. Maestroni, A. Conti, I. Portioli, Melatonin stimulates growth hormone secretion through pathways other than growth hormone-releasing hormone, Clin. Endocrinol. 39 (1993) 193-199.
64. [64] E. Moccheggiani, D. Bulian, L. Santarelli, A. Tibaldi, M. Muzzioli, V. Lesnikov, W. Pierpaoli, N. Fabris, The zinc pool is involved in the immune-reconstituting effect of melatonin in pinealectomized mice, J. Pharmacol. Exp. Ther. 277 (1996) 1200-1208.
65. [65] G. Del Prete, E. Maggi, S. Romagnani, Human Th1 and Th2 cells: functional properties, mechanisms of regulation and role in disease, Lab. Invest. 70 (1994) 299-307.
66. [66] H.J. Hiddinga, D.D. Isaak, R.V. Lewis, Enkephalin-containing peptides processed from proenkephalin significantly enhance the antibody-forming cell responses to antigens, J. Immunol. 152 (1994) 3748-3758.
67. [67] S. Sei, H. Akiyoshi, I. Bernard, D.J. Venzon, C.H. Fox, D.J. Schwartzentruber, B.D. Anderson, J.B. Kopp, B.U. Mueller, P.A. Pizzo, Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection, J. Infect. Dis. 173 (1996) 1485-1490.
68. [68] A.L. Kinter, S.M. Bende, E.G. Hardy, R. Jackson, A. Fauci, Interleukin 2 induces CDS+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression, Proc. Natl. Acad. Sci. USA 92 (1995) 10985-10989.
69. [69] Z.P. Bernstein, M.M. Porter, M. Gould, B. Lipman, E.M. Bluman, C.C. Stewart, R.G. Hewitt, G. Fyfe, B. Poiesz, M.A. Caligiuri, Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion on innate immune effectors without significant clinical toxicity, Blood 86 (1995) 3287-3294.